Nephros Reports 35% Revenue Growth to $4.76 Million in Latest Quarter

Nephros, Inc. reported significant financial growth in its latest quarterly filing, with total net revenues reaching $4.76 million for the three months ended September 30, 2025, a 35% increase from $3.52 million in the same period last year. For the nine months ending September 30, 2025, revenues totaled $14.06 million, up 37% from $10.29 million in 2024. The company achieved a net income of $337,000 for the third quarter and $1.13 million for the nine-month period, a substantial turnaround from a net loss of $275,000 in the prior year.

The increase in revenue was primarily driven by strong reorder activity and the addition of new active sites, particularly in the programmatic and emergency response segments. Gross margins improved to 61% for the third quarter and 63% for the nine months, compared to 61% for both periods in the previous year. This improvement was attributed to a favorable product mix and reduced inventory reserve adjustments, which helped lower the cost of goods sold.

Operationally, Nephros has seen a rise in its customer base and product adoption rates. The company reported an increase in accounts receivable, reflecting higher sales, and maintained a strong cash position with cash and cash equivalents of $5.17 million as of September 30, 2025, compared to $3.76 million at the end of 2024. The company’s total assets increased to $13.25 million, up from $11.21 million, while total liabilities rose to $3.24 million from $2.63 million, indicating a solid balance sheet.

Strategically, Nephros continues to focus on expanding its market presence, particularly in the medical and commercial water filtration sectors. The company has recently launched new products aimed at addressing emerging contaminants, including Total PFAS, which enhances its portfolio's appeal across various industries. Nephros operates primarily through value-added resellers (VARs) and has plans to leverage these relationships to further penetrate the market.

Looking ahead, Nephros aims to sustain its growth trajectory by managing expenses and increasing sales. The company is optimistic about maintaining profitability and positive cash flow, although it acknowledges potential challenges related to market conditions and competition. Nephros is committed to enhancing its operational efficiency and expanding its product offerings to meet the evolving needs of its customers.